Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 9 years
- Director since
- 2023
9 years of board service in total across 3 boards, counting each seat separately. Longest: Orchestra BioMed Holdings Inc., 3 years.
Orchestra BioMed Holdings Inc.
Director
Ligand Pharmaceuticals Incorporated
Director
Lifecore Biomedical Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 27, 2024 | Orchestra BioMed Holdings Inc. | Option exercise | +11,700 | $4.30 | $50,310 |
| Aug 19, 2024 | Lifecore Biomedical Inc. | Grant or award | +24,554 | — | — |
| Jun 20, 2024 | Orchestra BioMed Holdings Inc. | Grant or award | +5,376 | — | — |
| Jun 14, 2024 | Ligand Pharmaceuticals Incorporated | Grant or award | +1,252 | — | — |
| Apr 30, 2024 | Ligand Pharmaceuticals Incorporated | Option exercise | +2,406 | $52.30 | $125,834 |
| Mar 5, 2024 | Ligand Pharmaceuticals Incorporated | Option exercise | +2,893 | $39.35 | $113,840 |
| Jun 9, 2023 | Ligand Pharmaceuticals Incorporated | Grant or award | +1,142 | — | — |
| Apr 12, 2023 | Orchestra BioMed Holdings Inc. | Option exercise | +11,246 | — | — |
| Jan 26, 2023 | Orchestra BioMed Holdings Inc. | Grant or award | +51,738 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.